Murray Hill – Managing Director & CEO – Elevate Uranium (ASX:EL8) is a uranium exploration company that has significant resources in Namibia and Australia and is making new discoveries through active exploration programs.
Copyright 2024 – Finance News Network
Source: Finance News Network
21 Sep 2023 - Managing Director of Pacgold Limited (ASX:PGO) Tony Schreck discusses the company's key asset the Alice River Gold Project.
Read More10 Oct 2023 - Andrew Worland - Managing Director and Chief Executive Officer - International Graphite (ASX:IG6) is building Australia’s capability in critical battery minerals and establishing a new ethical supply of battery anode graphite to support the global revolution in clean energy.
Read More11 Apr 2023 - icetana Limited (ASX:ICE) CEO and Managing Director Matt Macfarlane discusses recent contracts and the company's new surveillance software.
Read More05 Feb 2021 - Centuria Office REIT (ASX:COF) Fund Manager Grant Nichols discusses 1H21 highlights, the market conditions for leasing, and the outlook and trends for office markets.
Read More20 Mar 2024 - PainChek Limited (ASX:PCK) CEO Philip Daffas provides an overview of the company, discussing its recent agreement with Nourish Care to expand into the UK market.
Read More19 Jul 2024 - DroneShield's CEO Oleg Vornik discusses the company's impressive share price surge and its cutting-edge counter-drone technology. He also highlights DroneShield's diverse revenue streams and expanding presence in global markets.
Read More31 May 2023 - European Metal Holdings Limited (ASX:EMH) Executive Chairman Keith Coughlan discusses the European demand for lithium and the scale of the company's Cinovec project.
Read More21 Jun 2021 - BluGlass Limited (ASX:BLG) Executive Chair, James Walker and Chief Technology and Operations Officer, Dr Ian Mann discuss the company's laser diode production and its recent rights issue.
Read More27 Jun 2023 - Chimeric Therapeutics Limited (ASX:CHM) CEO and Managing Director Jennifer Chow discusses promising results in the company's lead therapy for glioblastoma, and the timeline for the recently launched Phase 1b trial.
Read More23 Sep 2024 - Rob Hattersley, Group Head of Capital at MaxCap Group, provides an overview of the company, discussing the funding gap in the Australian credit market, managing risk, the tailwinds for commercial real estate debt, and opportunities within the residential and logistics property markets.
Read More
